28.01.2021: Phase I vaccine studies in the times of COVID-19

Phase 1 Vaccine Studies in the Times of Covid-19

Free webinar on 28 January 2021 at 16:00-17:45 CET

Invitation to our Early Medicines Development Community

COVID has highlighted the importance of Phase 1 trials with vaccines. And yet, only a handful of sponsors, Phase 1 sites and investigators have a thorough understanding of the science, methodology, ethics and logistics required to run such trials.

Our New Years EUFEMED webinar will provide you with cutting-edge insight into newest developments around such trials while also learning about the experience of others and providing an opportunity to discuss recommendations.

Registration & FAQ

What to expect

from 15:40 dial-in
Moderator: Jan de Hoon
Center for Clinical Pharmacology, KU Leuven, Belgium
16:00 Welcome and Introduction
16:10 An overview of current vaccine platforms and the development of a new vaccine against SARS-CoV-2
Johan Neyts, Rega Institute, KU Leuven, Belgium
16:40 The challenges of setting up a Phase 1 vaccine trial during the Corona pandemic:
The sponsor’s point of view
Johan Van Hoof, Janssen Pharmaceutica, Beerse, Belgium
17:10 The challenges of conducting a Phase 1 vaccine trial during the Corona pandemic:
The investigator’s point of view
Wouter Botermans, Center for Clinical Pharmacology, KU Leuven, Belgium
17:30 General Discussion
17:40 Closing remarks
Registration Free of charge (requested at the latest by 25/1/2021)
Organizer EUFEMED www.eufemed.eu
Contact via CSi Hamburg GmbH
Email: eufemed2021@csihamburg.de
Phone: +49 40 30770300

For registration and FAQ on participation:

please click here!

We look forward to your registration!

Download programme